-+ 0.00%
-+ 0.00%
-+ 0.00%

Smart Eye (OM:SEYE) Stock Selloff Clashes With 53% Revenue Growth

Simply Wall St·08/28/2026 02:33:23
Listen to the news

The market has punished Smart Eye for months, with the stock down roughly 40% over the past quarter, yet Q2 landed with a very different message. Revenue reached SEK140.9 million and trailing twelve month sales are SEK488.8 million, which keeps this driver monitoring specialist in clear growth mode even as losses persist. The latest quarterly loss of SEK27.0 million keeps the story high risk, but the sentiment gap is now stark. Price has been trading as if the balance sheet strain is the whole story. The earnings release indicates that investors need to look again.

Love Smart Eye's revenue growth but concerned that recurring losses keep the risk profile high? Take a look at our 300 resilient stocks with low risk scores for companies that pair solid fundamentals with more resilient risk scores.

Q2 2026 Earnings Summary

  • Revenue, Q2 2026 vs. Q2 2025: SEK140.9 million vs. SEK92.1 million (up about 53%)
  • Net Loss, Q2 2026 vs. Q2 2025: SEK27.0 million loss vs. SEK37.4 million loss (loss narrowed about 28%)
  • Basic EPS, Q2 2026 vs. Q2 2025: Not disclosed for Q2 2026 vs. SEK0.9996 loss per share in Q2 2025 (directional comparison not available)
  • Trailing 12 Month Revenue, Q2 2026 vs. Q2 2025: SEK488.8 million vs. SEK361.5 million (up about 35%)

If you prefer clear charts to a dense wall of numbers and footnotes, explore Smart Eye's full financial picture with an easy visual read on its valuation in our company report for Smart Eye.

OM:SEYE Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
OM:SEYE Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

Smart Eye’s Growth Story Versus Profit Progress

For investors leaning bullish on Smart Eye, the latest quarter keeps the growth story intact. Revenue in Q2 2026 reached SEK140.9 million compared with SEK92.1 million a year earlier, and trailing twelve month sales are SEK488.8 million versus SEK361.5 million. Losses remain, but the quarterly loss narrowed to SEK27.0 million from SEK37.4 million. That combination of higher sales and a smaller loss suggests the business model is scaling, even if it is not yet at breakeven.

Testing Smart Eye’s High Risk Narrative

The share price is down about 40% over 90 days, and Smart Eye still reported a SEK27.0 million loss in Q2 2026. That keeps the high risk label alive. However, the loss is smaller than the SEK37.4 million loss a year earlier while revenue is higher, which points to improving operating leverage rather than deterioration. The stock performance over the past quarter reflects concern about ongoing losses and balance sheet strain, but the direction of the income statement is less harsh than price action implies.

After a 40% share price fall and with less than one year of cash runway, Smart Eye’s risk story is not straightforward. Review our independent risk analysis for Smart Eye which shows 2 important warning signs

Take Control Of Your Next Move

If Smart Eye’s mix of strong revenue and ongoing losses has your attention, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch for an entry point that fits your plan. After you decide to invest, keep your holdings organised with the Portfolio Command Center so you filter out noise and only see the most important updates. For the longer term, tap into the collective experience of other investors through the Community and see how different perspectives line up with your thesis. By spotting potential catalysts and risks early, you give yourself a better chance of staying ahead of the market.

Seeking Fresh Alternatives Beyond Smart Eye

Some stocks are building quiet breakout momentum while most investors stay focused elsewhere. Use these fresh ideas before the data goes stale and the best entries are gone, act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.